Related Experiment Video
Updated: Jun 24, 2025

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
MiRNA let-7d-5p Alleviates Inflammatory Responses by Targeting Map3k1 and Inactivating ERK/p38 MAPK Signaling in
1Department of Geriatrics, Huangshi Central Hospital, Huangshi 435000, China.
Abstract:
Alzheimer's disease (AD) is the most common form of dementia. Aberrant regulation of microRNAs (miRNAs) has been implicated in the pathogenesis of AD. In a large case-control study recruiting 208 patients with AD and 205 elderly control subjects, miRNA-let-7d-5p attracted our attention for its downregulated level in patients with AD. However, the biological functions of let-7d-5p in AD pathogenesis have not been investigated. This study emphasized the functions and mechanisms of let-7d-5p in the pathogenesis of AD. Mouse microglial BV2 cells treated with amyloid-β (Aβ)1-42 were used as in vitro AD inflammation models. We reported that let-7d-5p was downregulated in Aβ1-42-stimulated BV2 cells, and upregulation of let-7d-5p promoted the transversion of microglial cells from Ml phenotype to M2 phenotype. Then, the binding relationship between let-7d-5p and Map3k1 was verified by luciferase reporter assays. Mechanistically, let-7d-5p could target Map3k1 3'UTR to inactivate ERK/p38 MAPK signaling. Therefore, it was suggested that let-7d-5p might be a novel modulator of microglial neuroinflammation and serve as a novel target for diagnosis and treatment of AD.
Insights
MicroRNA let-7d-5p is downregulated in Alzheimer's disease (AD). Upregulating this microRNA may help treat AD by reducing neuroinflammation via the Map3k1/ERK/p38 MAPK pathway.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alzheimer's disease (AD) is a leading cause of dementia.
- MicroRNAs (miRNAs) are implicated in AD pathogenesis.
- let-7d-5p was found to be downregulated in AD patients.
Purpose of the Study:
- Investigate the function and mechanisms of let-7d-5p in AD.
- Determine the role of let-7d-5p in microglial activation and neuroinflammation.
- Explore let-7d-5p as a potential therapeutic target for AD.
Main Methods:
- Used amyloid-beta (Aβ)1-42-treated BV2 cells as an in vitro AD model.
- Assessed let-7d-5p levels and microglial phenotype.
- Verified let-7d-5p binding to Map3k1 using luciferase reporter assays.
- Analyzed the effect of let-7d-5p on ERK/p38 MAPK signaling.
Main Results:
- let-7d-5p was downregulated in Aβ1-42-stimulated microglial cells.
- Upregulation of let-7d-5p promoted microglial M1 to M2 phenotype transition.
- let-7d-5p directly targets Map3k1 3'UTR.
- let-7d-5p inactivates ERK/p38 MAPK signaling.
Conclusions:
- let-7d-5p plays a crucial role in regulating microglial neuroinflammation in AD.
- let-7d-5p may serve as a novel diagnostic and therapeutic target for AD.
- The let-7d-5p/Map3k1 axis modulates microglial activation and neuroinflammation in AD.
Related Concept Videos
MicroRNAs
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

